Literature DB >> 10593026

Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.

L Simonsen1, A Kane, J Lloyd, M Zaffran, M Kane.   

Abstract

Unsafe injections are suspected to occur routinely in developing countries. We carried out a literature review to quantify the prevalence of unsafe injections and to assess the disease burden of bloodborne infections attributable to this practice. Quantitative information on injection use and unsafe injections (defined as the reuse of syringe or needle between patients without sterilization) was obtained by reviewing the published literature and unpublished WHO reports. The transmissibility of hepatitis B and C viruses and human immunodeficiency virus (HIV) was estimated using data from studies of needle-stick injuries. Finally, all epidemiological studies that linked unsafe injections and bloodborne infections were evaluated to assess the attributable burden of bloodborne infections. It was estimated that each person in the developing world receives 1.5 injections per year on average. However, institutionalized children, and children and adults who are ill or hospitalized, including those infected with HIV, are often exposed to 10-100 times as many injections. An average of 95% of all injections are therapeutic, the majority of which were judged to be unnecessary. At least 50% of injections were unsafe in 14 of 19 countries (representing five developing world regions) for which data were available. Eighteen studies reported a convincing link between unsafe injections and the transmission of hepatitis B and C, HIV, Ebola and Lassa virus infections and malaria. Five studies attributed 20-80% of all new hepatitis B infections to unsafe injections, while three implicated unsafe injections as a major mode of transmission of hepatitis C. In conclusion, unsafe injections occur routinely in most developing world regions, implying a significant potential for the transmission of any bloodborne pathogen. Unsafe injections currently account for a significant proportion of all new hepatitis B and C infections. This situation needs to be addressed immediately, as a political and policy issue, with responsibilities clearly defined at the global, country and community levels.

Entities:  

Keywords:  Behavior; Biology; Communicable Diseases; Developing Countries; Diseases; Equipment And Supplies; Hepatitis--transmission; Hiv Infections--transmission; Infections; Literature Review; Measurement; Prevalence; Research Methodology; Risk Behavior; Risk Factors; Syringe; Viral Diseases

Mesh:

Year:  1999        PMID: 10593026      PMCID: PMC2557743     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  125 in total

Review 1.  Global impact of human immunodeficiency virus and AIDS.

Authors:  H D Gayle; G L Hill
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Measles eradication: is it in our future?

Authors:  W A Orenstein; P M Strebel; M Papania; R W Sutter; W J Bellini; S L Cochi
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

3.  Immunisation safety: a priority of the World Health Organization's Department of Vaccines and Biologicals.

Authors:  P Duclos; C A Hofmann
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  Non-sexual transmission of HIV has been overlooked in developing countries.

Authors:  David Gisselquist; Richard Rothenberg; John Potterat; Ernest Drucker
Journal:  BMJ       Date:  2002-01-26

5.  Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells.

Authors:  Anne-Sophie Beignon; Jean-Paul Briand; Sylviane Muller; Charalambos D Partidos
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

Review 6.  AIDS policy modeling for the 21st century: an overview of key issues.

Authors:  M S Rauner; M L Brandeau
Journal:  Health Care Manag Sci       Date:  2001-09

Review 7.  Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates.

Authors:  Yvan J F Hutin; Anja M Hauri; Gregory L Armstrong
Journal:  BMJ       Date:  2003-11-08

Review 8.  Post-exposure prophylaxis for blood borne viral infections in healthcare workers.

Authors:  G M Varghese; O C Abraham; D Mathai
Journal:  Postgrad Med J       Date:  2003-06       Impact factor: 2.401

9.  Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1.

Authors:  William M Gwinn; Shaun M Kirwan; Sheena H Wang; Kathleen A Ashcraft; Neil L Sparks; Catherine R Doil; Tom G Tlusty; Leslie S Casey; Susan K Hollingshead; David E Briles; Richard S Dondero; Anthony J Hickey; W Michael Foster; Herman F Staats
Journal:  Vaccine       Date:  2010-08-17       Impact factor: 3.641

10.  Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines.

Authors:  Paul E Makidon; Shraddha S Nigavekar; Anna U Bielinska; Nicholas Mank; Abhishek M Shetty; Julie Suman; Jessica Knowlton; Andrzej Myc; Trent Rook; James R Baker
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-04       Impact factor: 2.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.